Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI

2017 
Jessica L. Mega, MD, MPH Tabassome Simon, MD, PhD Jean-Philippe Collet, MD, PhD Jeffrey L. Anderson, MD Elliott M. Antman, MD Kevin Bliden, BS Christopher P. Cannon, MD Nicolas Danchin, MD, PhD Betti Giusti, PhD Paul Gurbel, MD Benjamin D. Horne, PhD Jean-Sebastian Hulot, MD, PhD Adnan Kastrati, MD Gilles Montalescot, MD, PhD Franz-Josef Neumann, MD Lei Shen, PhD Dirk Sibbing, MD P. Gabriel Steg, MD Dietmar Trenk, PhD Stephen D. Wiviott, MD Marc S. Sabatine, MD, MPH
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    45
    References
    34
    Citations
    NaN
    KQI
    []